| |
|
|
|
scPharmaceuticals Inc.  
|
|
3.58 -0.12 (-0.03%) |
01-18 16:00 |
|
Open: |
3.69 |
Pre close: |
3.7 |
Target:
|
5.11
|
|
High: |
3.7725 |
Low: |
3.5 |
Resistance:
|
4.38
5.00
|
|
Volume: |
34,482 |
Market Cap: |
66M |
Support:
|
3.37
2.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.74
 |
MACD |
MACD(12,26):
|
-0.22 |
|
MA(20): |
3.95 |
Signal(12,26,9): |
-0.22 |
|
MA(100): |
4.70 |
Stochastic Oscillator |
%K(14,3):
|
26.35 |
|
MA(250): |
7.89 |
%D(3): |
30.37 |
|
Average Volume(K) |
3-Month: |
3210
|
52-Week |
High:
|
17.95 |
|
10-Days: |
5360 |
Low: |
3.37 |
|
RSI |
RSI(14):
|
34.11 |
Change(%): |
-70.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-60.7 |
Shares Out. (M) |
18.57 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-47.2 |
Shares Float (M) |
18.50 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
47.10 |
|
Forward EPS |
-2.159 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.870 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.11 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.95 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-18.53 |
P/CF |
-2.30 |
|
|
|
|
|
|
